Advice on the sale of a medtech rehabilitation robotics company
Summary
ST strategy advised the shareholders on the search for a strategic partner for the company.
An ageing population and pressure on healthcare systems are driving demand for more efficient rehabilitation solutions. Robotics and artificial intelligence open new possibilities in physiotherapy.
RehabRobotics* developed a robotic medical device that treats musculoskeletal conditions without contact, using thermoregulated pressurised air, thermography and AI-based body recognition. It holds European medical certification, has units installed in hospitals and clinics and distribution agreements in several countries.
ST strategy advised the shareholders on the search for a buyer or strategic partner to fund the next generation of the product.
Medtech
Sale of the company
Robotics and AI
The full story
Opportunity
With a certified product and first sales, the company needed significant resources to develop the second version of the robot and scale commercially. Integration into a medtech group was the most efficient route.
Recommendations
Based on the analysis carried out by ST strategy, we worked on the process:
- Financial plan and valuation: Preparation of the business plan and the approximation of value using five methods, based on the analysis of more than 250 transactions, plus an intangible assets valuation report.
- Quality of Earnings: Report on the consistency of the financial projections to give buyers confidence.
- Documentation: All the documents needed to go to market were prepared (Information Memorandum, Teaser, factsheet and Screening).
- International process: Selection of the best-fit strategic buyers in Europe, America and Asia (rehabilitation robotics and large medtech groups) and outreach to more than 50 companies.
* The confidentiality of our clients is a priority of the company. Although we have changed their names, the information is real.